375 related articles for article (PubMed ID: 20932714)
1. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
Han DK; Shah TR; Ellozy SH; Vouyouka AG; Marin ML; Faries PL
Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
[TBL] [Abstract][Full Text] [Related]
2. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
3. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
de Grijs D; Teixeira P; Katz S
J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
[TBL] [Abstract][Full Text] [Related]
4. Endovascular interventions for TASC II D femoropopliteal lesions.
Baril DT; Chaer RA; Rhee RY; Makaroun MS; Marone LK
J Vasc Surg; 2010 Jun; 51(6):1406-12. PubMed ID: 20385464
[TBL] [Abstract][Full Text] [Related]
5. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
6. Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option.
Chen BL; Holt HR; Day JD; Stout CL; Stokes GK; Panneton JM
J Vasc Surg; 2011 Feb; 53(2):367-73. PubMed ID: 21030201
[TBL] [Abstract][Full Text] [Related]
7. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
8. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment.
Rabellino M; Zander T; Baldi S; Garcia Nielsen L; Aragon-Sanchez FJ; Zerolo I; Llorens R; Maynar M
Catheter Cardiovasc Interv; 2009 Apr; 73(5):701-5. PubMed ID: 19309709
[TBL] [Abstract][Full Text] [Related]
9. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
[TBL] [Abstract][Full Text] [Related]
10. Cryoplasty as endovascular treatment in the femoropopliteal region: hemodynamic results and follow-up at one year.
Gonzalo B; Solanich T; Bellmunt S; Herranz C; González E; Arnedo G; Muñoz G; Florit S; Hospedales J; Lloret MD; Vallespín J; Giménez A
Ann Vasc Surg; 2010 Jul; 24(5):680-5. PubMed ID: 20409679
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
[TBL] [Abstract][Full Text] [Related]
12. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
[TBL] [Abstract][Full Text] [Related]
13. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
[TBL] [Abstract][Full Text] [Related]
14. Endovascular treatment for symptomatic stent failures in long-segment chronic total occlusion of femoropopliteal arteries.
Yang X; Lu X; Li W; Huang Y; Huang X; Lu M; Jiang M
J Vasc Surg; 2014 Aug; 60(2):362-8. PubMed ID: 24680242
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
Costanza MJ; Queral LA; Lilly MP; Finn WR
J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
19. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
[TBL] [Abstract][Full Text] [Related]
20. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.
Grenville JL; Tan KT; Moshonov H; Rajan DK
Vascular; 2015 Feb; 23(1):31-40. PubMed ID: 24695358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]